About Stenora
Stenora is a Healthcare company. Pharmaceutical manufacturing and exporting of drugs in India. Its Indian entity Stenora Pharma Private Limited reported revenue of ₹87.2 Lakh. Stenora offers products and services including Anticancer Drugs and Cardiac Drugs. Its focus areas include Export Services, International Trade, Pharmaceutical Exports and Pharmaceuticals.
Company details
Stenora Pharma Pvt. Ltd. is recognized as a fast-emerging pharmaceutical organization based in Mumbai, India, that manufactures and exports products such as anticancer, cardiac, and other drugs to regions including CIS countries, Africa, and Central America. It is certified under ISO 9001:2015 and utilizes advanced technology with expert teams to ensure quality and safety. The companys vision involves becoming a leading global player, while its mission focuses on developing competitive products that add value to pharmaceuticals. Values like integrity and responsibility are emphasized in serving customer needs.
- SectorsHealthcare
- Email••••••••
- Legal Name Stenora Pharma Pvt. Ltd
- Date of Incorporation 10 May, 2018
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹87.2 Lakh
FY 2025 · +14% YoY
- Indian entity net profit₹4.6 Lakh
FY 2025 · 5% margin
- Indian entity EBITDA₹7.2 Lakh
FY 2025 · 8% margin
Associated legal entities of Stenora
Stenora operates through Stenora Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stenora Pharma Private Limited CIN U74993MH2018PTC309229 | Active | 10 May 2018 | Mumbai, Maharashtra | ₹0.9 Cr | 2 | View details |
Products & Services of Stenora
Stenora offers a comprehensive portfolio of products and services, including Anticancer Drugs and Cardiac Drugs.
Anticancer drugs are formulated for the treatment of cancer using state-of-the-art technology and expert teams.
Cardiac drugs are produced for cardiovascular health management with a focus on quality and safety.
Board of directors of Stenora Pharma Private Limited (Stenora)
Stenora Pharma Private Limited is the primary company behind Stenora. The board of Stenora Pharma Private Limited currently have 2 directors; the longest-serving is Arvind Kumar Sheo Kumar Shahi, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arvind Kumar Sheo Kumar Shahi DIN 02023730 | Director | 10 May 2018 | 8 yrs 5 mo | Stenora Pharma Private Limited |
| Rinki Shahi DIN 02367820 | Director | 10 May 2018 | 8 yrs 5 mo | Stenora Pharma Private Limited |
Financials of Stenora
Figures of Stenora Pharma Private Limited, the primary company behind Stenora, for FY 2025. Revenue was ₹87.2 Lakh (+14% year on year). Net profit was ₹4.6 Lakh (5% margin). EBITDA was ₹7.2 Lakh (8% margin). Revenue has grown at a compounded annual rate of -1% over three years and +153% over five years.
- ₹87.2 LakhRevenue · FY 2025 · +14% YoY
- ₹4.6 LakhNet profit · 5% margin
- ₹7.2 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- -1%Revenue CAGR, 3 years
- +153%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Stenora Pharma Private Limited are on its company page.
Detailed financial statements for Stenora
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stenora
The primary company behind Stenora, Stenora Pharma Private Limited, reported revenue of ₹87.2 Lakh for FY 2025, up 14% year on year.
Stenora Pharma Pvt. Ltd. is recognized as a fast-emerging pharmaceutical organization based in Mumbai, India, that manufactures and exports products such as anticancer, cardiac, and other drugs to regions including CIS countries, Africa, and Central America. It is certified under ISO 9001:2015 and utilizes advanced technology with expert teams to ensure quality and safety. The companys vision involves becoming a leading global player, while its mission focuses on developing competitive products that add value to pharmaceuticals. Values like integrity and responsibility are emphasized in serving customer needs.
Stenora offers Anticancer Drugs and Cardiac Drugs.
Stenora operates through Stenora Pharma Private Limited.
The legal entities of Stenora currently have 2 directors, including Arvind Kumar Sheo Kumar Shahi, Rinki Shahi.